Loading clinical trials...
Loading clinical trials...
To verify the non-inferiority of NK105, a paclitaxel-incorporating micellar nanoparticle, to paclitaxel in terms of the progression-free survival in patients with metastatic or recurrent breast cancer...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Nippon Kayaku Co., Ltd.
NCT01554371 · Malignant Solid Tumour, Breast Cancer Nos Metastatic Recurrent, and more
NCT01711502 · Breast Cancer Nos Metastatic Recurrent
Japan Sites
Tokyo, Etc.
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions